Delivering the Next Generation of Biopharma
Pathos (pathos.com) earns a Brand Analyzer score of 71 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, Pathos ranks in the 68th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 82/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 60/100, AI Discoverability 70/100, Brand Authority 27/100.
Pathos is a healthcare technology company operating at the intersection of artificial intelligence, biological modeling, and oncology data. The company integrates these capabilities to improve the precision and efficiency of clinical trials. Its platform draws on what it describes as the largest collection of oncology patient data to support biopharma companies and drug developers in making more informed, data-driven decisions during the drug development process.
| Brand Name | Pathos |
|---|---|
| Domain | pathos.com |
| Industry | Healthcare, Technology |
| Main Competitors | Tempus AI (76/100), Flatiron Health, Medidata Solutions, Foundation Medicine (73/100), Veeva Systems (81/100), Syapse |
Moz Domain Authority 25/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #4,379,803 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Pathos integrates AI technology, biological modeling, and the largest collection of oncology patient data to make clinical trials smarter and more precise." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, GitHub; no detected presence on X (Twitter), YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Pathos scores 26/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Pathos has a weak AI-visibility profile at 26/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #4,379,803 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 25/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Pathos's main competitors include Tempus AI (76/100), Flatiron Health, Medidata Solutions, Foundation Medicine (73/100), Veeva Systems (81/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Pathos official site
Pathos and Veeva Systems are competitors in Healthcare. Brand Analyzer scores Pathos at 71/100 and Veeva Systems at 81/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Pathos official site
Popular alternatives to Pathos include Tempus AI (76/100), Flatiron Health, Medidata Solutions, Foundation Medicine (73/100), Veeva Systems (81/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Pathos official site
Pathos has limited AI-search visibility, scoring 26/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 29, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Pathos official site
Pathos scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Pathos official site
Pathos integrates AI technology, biological modeling, and oncology patient data to make clinical trials smarter and more precise. By combining these capabilities, Pathos aims to eliminate guesswork in drug development, enabling biopharma companies and oncology researchers to design and execute more efficient and targeted clinical trials. Its approach is intended to accelerate biopharma innovation by grounding trial decisions in large-scale, real-world patient data and advanced computational modeling.
Sources: Pathos official site
Pathos can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Pathos official site
Pathos targets biopharma companies, drug developers, and oncology researchers. These are organizations and professionals involved in designing, running, or funding clinical trials, particularly in the oncology space. The platform is built to serve those seeking more efficient, precise, and data-driven approaches to drug development and clinical trial execution.
Sources: Pathos official site
Pathos is a healthcare technology company that combines artificial intelligence, biological modeling, and oncology patient data to improve clinical trials. It operates in the biopharma and oncology research space, positioning itself as an AI-powered platform designed to make drug development more data-driven and precise. The company describes its data repository as the largest collection of oncology patient data available for this purpose.
Sources: Pathos official site
Pathos is known for integrating AI technology, biological modeling, and what it describes as the largest collection of oncology patient data to enhance the precision of clinical trials. It is recognized within the biopharma and oncology research space for its data-driven approach to drug development, aiming to reduce uncertainty and improve outcomes in the clinical trial process.
Sources: Pathos official site
Ranked closest to Pathos: Parenting Research Centre (71/100), Parambil (71/100), PerformYard (71/100), Phelix AI (71/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).